Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Efavirenz”

298 trials

Showing 20 of 298 results

Testing effectiveness (Phase 2)Study completedNCT00964171
What this trial is testing

Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Institut Bergonié 19
Not applicableStudy completedNCT01138267
What this trial is testing

Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 450
Early research (Phase 1)Study completedNCT01878890
What this trial is testing

Phase I Dose Escalation Trial of Efavirenz in Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure.

Who this might be right for
Solid TumorsNon-Hodgkin's Lymphoma
Institut Bergonié 25
Post-approval studies (Phase 4)Study completedNCT00924898
What this trial is testing

Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)

Who this might be right for
Acute HIV InfectionHIV Infections
University of North Carolina, Chapel Hill 92
Early research (Phase 1)Study completedNCT00482963
What this trial is testing

The Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication

Who this might be right for
HIV InfectionsContraceptionPharmacokinetics
University of Colorado, Denver 24
Not applicableNo Longer AvailableNCT00162227
What this trial is testing

An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection

Who this might be right for
HIV Infection
Bristol-Myers Squibb
Very early researchLooking for participantsNCT05789173
What this trial is testing

Interaction of CYP2B6 Genotype and Efavirenz With Methadone and Tizanidine PK

Who this might be right for
Drug-Drug Interaction
Indiana University 60
Post-approval studies (Phase 4)Study completedNCT00245986
What this trial is testing

Effect of Genetics on Metabolism of Efavirenz

Who this might be right for
Metabolism
National Institutes of Health Clinical Center (CC) 350
Testing effectiveness (Phase 2)Study completedNCT03982277
What this trial is testing

Safety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral Therapy

Who this might be right for
Tuberculosis
Makerere University 130
Post-approval studies (Phase 4)Study completedNCT00771498
What this trial is testing

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

Who this might be right for
HIV InfectionTuberculosis
Oswaldo Cruz Foundation 30
Testing effectiveness (Phase 2)Study completedNCT00002227
What this trial is testing

Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Dupont Merck 60
Large-scale testing (Phase 3)Study completedNCT00002230
What this trial is testing

A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients

Who this might be right for
HIV Infections
Northwestern University 100
Large-scale testing (Phase 3)Study completedNCT00158457
What this trial is testing

Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 40
Early research (Phase 1)Study completedNCT03762928
What this trial is testing

ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZ

Who this might be right for
Healthy Subjects
Pfizer 12
Post-approval studies (Phase 4)Study completedNCT00116116
What this trial is testing

DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Who this might be right for
HIV InfectionsAIDS
Bristol-Myers Squibb 70
Post-approval studies (Phase 4)Study completedNCT01989910
What this trial is testing

Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients

Who this might be right for
HIV-1 Infection
Taipei Veterans General Hospital, Taiwan 107
Large-scale testing (Phase 3)Study completedNCT01309243
What this trial is testing

Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 799
Not applicableStudy completedNCT02249962
What this trial is testing

Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART

Who this might be right for
HIVInfant Exposure to Efavirenz
University of North Carolina, Chapel Hill 12,011
Large-scale testing (Phase 3)Study completedNCT00323544
What this trial is testing

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

Who this might be right for
HIV Infections
Gilead Sciences 220
Not applicableUnknownNCT00525239
What this trial is testing

HIV Antiretroviral Drugs and Metabolism

Who this might be right for
HIV Infections
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation